Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
28 February 2026
| Name: | APIAM ANIMAL HEALTH LIMITED (AHX) |
| ISIN: | AU000000AHX0 |
| Date of Listing: | 15 December 2015 |
| Date of Delisting: | 23 February 2026 |
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 23 February 2026.Legal Status:
ACN*: 604 961 024ABN: 50 604 961 024
Registration Date: 25 March 2015
Capital Gains Tax (CGT) Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
* ARBN if foreign entity
REGISTRY:
BoardRoom Australia
Level 8, 210 George Street, Sydney NSW 2000
GPO Box 3993 Sydney NSW 2001
Tel : 1300 737 760 (in Australia) +61 2 9290 9600 (International)
Fax : Within Australia: 1300 653 459 Outside Australia: +61 2 9279 0664
RegistryWebsite RegistryEmail
delisted at entity's request under Listing Rule 17.11 | 23/02/2026 |
we understand Pepper Bidco Pty Ltd and Pepper Holdco Limited, entities controlled by Adamantem Capital Fund II, which is managed and advised by Adamantem Capital Management Pty Ltd, acquired all of the issued shares in AHX - the All Scrip electors received 0.87 HoldCo Shares per Apiam share, reduced to reflect the Special Dividend of $0.10 and there were two mixed consideration options | 23/02/2026 |
Apiam is pleased to confirm that the Scheme has been implemented today, 23 February 2026. Accordingly, Apiam is now a wholly owned subsidiary of BidCo. On Monday, 16 February 2026, the fully franked special dividend of $0.10 per Apiam Share was paid to Apiam Shareholders who were recorded on the Apiam Share Register on the Special Dividend Record Date (being 7.00pm (Melbourne time) on Friday, 13 February 2026). Accordingly, the Scheme Consideration has been adjusted in accordance with the terms of the Scheme to reflect the payment of the Special Dividend. Apiam Shareholders who have not made a valid Election (or have made a valid Election to receive the All Cash Consideration) have today been sent an amount of $0.77 cash for each Apiam Share held as at the Scheme Record Date, being 7.00pm (Melbourne time) on Wednesday, 18 February 2026. | 22/02/2026 |
The securities of Apiam Animal Health Limited will be suspended from quotation at the close of trading on 6 February 2026 under Listing Rule 17.2, following lodgement of the Supreme Court of New South Wales orders with ASIC approving the scheme of arrangement by which by Pepper Bidco Pty Ltd and Pepper Holdco Limited, entities controlled by Adamantem Capital Fund II, which is managed and advised by Adamantem Capital Management Pty Ltd, will acquire all of the issued shares in AHX. | 06/02/2026 |
listed entity carried for record purposes only | 15/12/2015 |
delisted at entity's request under Listing Rule 17.11 | 23/02/2026 |
we understand Pepper Bidco Pty Ltd and Pepper Holdco Limited, entities controlled by Adamantem Capital Fund II, which is managed and advised by Adamantem Capital Management Pty Ltd, acquired all of the issued shares in AHX - the All Scrip electors received 0.87 HoldCo Shares per Apiam share, reduced to reflect the Special Dividend of $0.10 and there were two mixed consideration options | 23/02/2026 |
Apiam is pleased to confirm that the Scheme has been implemented today, 23 February 2026. Accordingly, Apiam is now a wholly owned subsidiary of BidCo. On Monday, 16 February 2026, the fully franked special dividend of $0.10 per Apiam Share was paid to Apiam Shareholders who were recorded on the Apiam Share Register on the Special Dividend Record Date (being 7.00pm (Melbourne time) on Friday, 13 February 2026). Accordingly, the Scheme Consideration has been adjusted in accordance with the terms of the Scheme to reflect the payment of the Special Dividend. Apiam Shareholders who have not made a valid Election (or have made a valid Election to receive the All Cash Consideration) have today been sent an amount of $0.77 cash for each Apiam Share held as at the Scheme Record Date, being 7.00pm (Melbourne time) on Wednesday, 18 February 2026. | 22/02/2026 |
The securities of Apiam Animal Health Limited will be suspended from quotation at the close of trading on 6 February 2026 under Listing Rule 17.2, following lodgement of the Supreme Court of New South Wales orders with ASIC approving the scheme of arrangement by which by Pepper Bidco Pty Ltd and Pepper Holdco Limited, entities controlled by Adamantem Capital Fund II, which is managed and advised by Adamantem Capital Management Pty Ltd, will acquire all of the issued shares in AHX. | 06/02/2026 |
listed entity carried for record purposes only | 15/12/2015 |
Your browser may reflect a date of printing in American format.
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 19/06/2025 | Vita Pepe | 78,625 | $0.440 | $34,571 | |
| 16/06/2025 | Vita Pepe | 68,238 | $0.398 | $27,159 | |
| 25/03/2025 | Chris Richards | 165,032 | $0.394 | $64,990 | |
| 24/03/2025 | Chris Richards | 112,406 | $0.362 | $40,736 | |
| 31/05/2024 | Chris Richards | 38,209 | $0.363 | $13,885 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Bruce Dixon | Managing Director | 07/10/2024 |
| Vita Pepe | Non Exec Director | 13/06/2025 |
| Anthony Kerwick | Director | 23/02/2026 |
| Angus Stuart | Director | 23/02/2026 |
| Matthew White | Company Secretary | 23/02/2026 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Andrew Visard | Chairman | 07/11/2015 | 23/02/2026 |
| Richard Dennis | Non Exec Director | 07/11/2015 | 23/02/2026 |
| Evonne Collier | Non Exec Director | 30/09/2022 | 23/02/2026 |
| Natalie Climo | Company Secretary | 25/11/2025 | 23/02/2026 |
| Eryl Baron | Company Secretary | 25/11/2025 | |
| Chris Richards | Managing Director, CEO | 27/03/2015 | 05/06/2025 |
| Jan Tennent | Non Exec Director | 01/08/2018 | 21/11/2024 |
| Michael van Blommestein | Non Exec Director | 07/11/2015 | 24/11/2022 |
| Charles Sitch | Non Exec Director | 15/12/2015 | 29/11/2018 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2026 Investogain Pty Limited. All rights reserved.